Insider Ledger
LeonaBio, Inc. (LONA) insider buying and SEC filings
LeonaBio, Inc. · CIK 1620463
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- Fiscal year end
- Dec 31
- Former names
- Athira Pharma, Inc.; M3 Biotechnology, Inc.
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$99K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Mar 4, 2026 | Sale | Robert Renninger (CFO) sold 906 shares at about $5.37 ($5K). Holdings down 5% to 15,851 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Mar 4, 2026 | Sale | Mark Worthington (GENERAL COUNSEL and CCO) sold 1,328 shares at about $5.37 ($7K). Holdings down 7% to 18,376 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Mar 4, 2026 | Sale | Kevin Church (Chief Scientific Officer) sold 1,359 shares at about $5.37 ($7K). Holdings down 5% to 25,178 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Mar 4, 2026 | Sale | Martin Javier San (Chief Medical Officer) sold 1,720 shares at about $5.37 ($9K). Holdings down 10% to 15,887 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Mar 4, 2026 | Sale | Mark James Litton (CEO and Director) sold 5,156 shares at about $5.37 ($28K). Holdings down 8% to 57,926 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Jan 2, 2026 | Sale | Mark Worthington (General Counsel and CCO) sold 876 shares at about $6.88 ($6K). Holdings down 6% to 13,978 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 5, 2026 |
| Jan 2, 2026 | Sale | Martin Javier San (Chief Medical Officer) sold 1,644 shares at about $6.88 ($11K). Holdings down 14% to 10,189 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 5, 2026 |
| Jan 2, 2026 | Sale | Mark James Litton (CEO and Director) sold 2,586 shares at about $6.88 ($18K). Holdings down 6% to 40,828 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 5, 2026 |
| Jan 2, 2026 | Sale | Robert Renninger (CFO) sold 297 shares at about $6.88 ($2K). Holdings down 2% to 12,857 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 5, 2026 |
| Jan 2, 2026 | Sale | Kevin Church (Chief Scientific Officer) sold 876 shares at about $6.88 ($6K). Holdings down 4% to 20,681 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 5, 2026 |
43 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow LONA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.